-
ALSO READ
Glenmark Pharmaceuticals gets USFDA approval for Teriflunomide Tablets
Glenmark gets USFDA nod for multiple sclerosis medication
Zydus Cadila gets USFDA nod for Teriflunomide tablets
Sanofi Launches 'Once Daily' Oral, Teriflunomide 14 mg Tablet 'Aubagio'- for Treatment of Multiple Sclerosis in India
Zydus Cadila gets USFDA nod for generic cholesterol drug
-
S., LLC (Sanofi-Aventis). Teriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis.
Teriflunomide Tablets, 7 mg and 14 mg have an estimated market size of US$ 1.6 billion for twelve months ending December 2018 according to IQVIA. Alembic has settled the litigation and will launch the product as per the terms of the settlement.
Alembic now has a total of 91 ANDA approvals (79 final approvals and 12 tentative approvals) from USFDA.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Subscribe to Business Standard Premium
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.
Download the Business Standard App for latest Business News and Market News .
RECOMMENDED FOR YOU